Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

Select Filters
Executive Resource Center
See how fraud analytics can identify red flags, detect schemes sooner and strengthen fraud monitoring and investigations.
Weaver helped a county hospital district evaluate FMV lease economics, asset values and strategic alternatives for a hospital operator transition.
Employer health benefit costs may see their largest increase since 2003. Explore the valuation and reimbursement implications.
Explore the DOJ’s new fraud enforcement priorities and what increased focus on health care means for providers, investors and advisors.
Explore U.S. life sciences trends in patents, clinical trials, private capital, M&A and public markets in the first half of 2026.
Federal immunization program planning and governance can be critical in a program’s first year. Learn how Weaver helped establish a strong foundation.
In a recent Medical Journal - Houston publication, David Lange explores how proposed SEC changes could make going public easier for life sciences firms.
Learn how Weaver's independent valuation supported a fair market value determination in a multimillion-dollar health care ownership dispute.
Explore how Medicare Advantage benefit changes and higher cost sharing may affect provider revenue, utilization forecasts and health care valuation.
ASC growth continues across the U.S., but acquisition targets remain limited as more centers form through joint ventures and institutional partnerships.
Learn how Weaver's health care disputes and investigations team quantified $81.5 million in alleged damages related to breach of fiduciary duty claims and diverted corporate opportunities.
Growth in outpatient joint procedures boomed, then slowed. Explore what’s driving the shift and valuation implications for ambulatory surgery centers.
1 2 3 4 … 14